Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Balance Sheet 2020–2025
| Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 280.7M | 376.7M | 462.3M | 375.4M | 438.8M | 486.1M |
| Cash & Equivalents | 32.3M | 37.2M | 85.4M | 44.0M | 57.2M | 87.1M |
| Liabilities | ||||||
| Total Liabilities | 216.0M | 247.8M | 245.5M | 54.1M | 39.4M | 30.6M |
| Long-Term Debt | 54.8M | 53.9M | 21.2M | 22.4M | 1.1M | 3.8M |
| Equity | ||||||
| Shareholders' Equity | 64.7M | 128.8M | 216.7M | 321.3M | 399.4M | 455.6M |
Enanta Pharmaceuticals Inc. Balance Sheet — FAQ
Enanta Pharmaceuticals Inc. (ENTA) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's balance sheet history?
The chart and table above show Enanta Pharmaceuticals Inc.'s balance sheet by year and by quarter, including the growth rate.